WeightWatchers Enhances Enterprise Offering with Full-Spectrum Access to Weight Health
06 Outubro 2023 - 10:15AM
WeightWatchers (NASDAQ: WW), (“WeightWatchers,” “WW,” or the
“Company”) announced today that WeightWatchers for Business has
fully integrated WW’s science-proven behavioral program with its
virtual obesity clinic and medication management. The Company now
offers a full spectrum weight health platform designed for
employers and health plans, that delivers individualized member
pathways based on true clinical need.
As prevalence of chronic diseases increases, organizations are
challenged with higher costs, with experts predicting a 2-10%
increase in insurance premiums in 20241. Among the many
contributing factors are the increased utilization and cost of
GLP-1 medications indicated for weight loss and diabetes. To help
organizations navigate this new landscape, WeightWatchers for
Business is building on its 30+ years of science-backed expertise
in the employer-sponsored healthcare space with a complete cost
management and utilization strategy that includes preventing
progression and facilitating remission of weight-related
conditions, as well as managing weight before, during, and after
pharmacotherapy. WeightWatchers for Business utilizes
evidence-based clinical pathways and step therapy with proprietary
de-escalation protocols designed to drive clinically significant
outcomes while controlling cost.
“Health plans, PBMs, and their clients are grappling with
unprecedented demand for this new class of chronic weight
management medications and the associated costs,” stated Kevin
O'Brien, Senior Vice President of Commercial Growth and Customer
Operations for WeightWatchers. “Organizations are likely to face
higher expenditures in this category, extending beyond the
treatment of obesity. Our aim is to guide our partners to manage
costs at scale, while providing long-term weight health for their
people.”
The complete weight health platform includes:
- WW’s science-proven behavior change program for sustained
outcomes, including a program tailored for diabetes, as well as,
later this year, a program tailored for those on GLP-1
medications
- Robust virtual and in-real-life community
- Coach support at scale
- Integrated health insights
- Virtual clinic care and medication management, including GLP-1s
when appropriate, under the guidance of obesity medicine trained
healthcare providers
WeightWatchers’ virtual clinic members have seen an average of
20.7% weight loss after 12 months2. In addition, WeightWatchers’
third-party validated ROI model shows a 3.9x ROI for employers when
implementing WW’s full-spectrum program.
To further WeightWatchers’ commitment to providing the most
clinically-proven tools and interventions surrounding weight
health, the Company has appointed Amy Meister, D.O., M.R.O., Chief
Medical Officer to lead access to global medical services across
the business. Serving in this role, Dr. Meister will deliver the
highest standard of care for the WeightWatchers membership as well
as provide leadership across the complete health platform with
behavioral science, clinical solutions and in-person
experiences.
“As an internal medicine physician, treating people living with
obesity has been core to my practice for my entire career – and I
believe no one is better positioned to partner with employers to
address this challenge across all populations than WeightWatchers,”
said Dr. Meister, “I am confident that this best-in-class
combination of digital intensive lifestyle intervention with care
delivery will drive positive outcomes in holistically addressing
weight health.”
Dr. Meister brings over 23 years of experience with a strong
background in population health management, care delivery best
practices, including virtual health, and managed care services,
which will serve in shaping the future medical practices of the
business.
“With the appointment of Dr. Meister and our dedication to
serving the employer community and beyond, we are furthering our
mission to expand weight health care access and equity of treatment
to generate better health outcomes for all,” said Sima Sistani, CEO
of WeightWatchers.
Learn more about WeightWatchers for Business at
ww.com/forbusiness, or by visiting the WeightWatchers booth at the
2023 HLTH Conference in the Las Vegas Convention Center (located at
4641, West Hall), October 8 - 11, 2023.
About WW International, Inc.WeightWatchers is a
human-centric technology company powered by our proven,
science-based, clinically effective weight loss and weight
management program. For six decades, we have inspired millions of
people to adopt healthy habits for real life. We combine technology
and community to help members reach and sustain their goals on
our program. To learn more about the WeightWatchers approach to
healthy living, please visit ww.com. For more information about our
global business, visit our corporate website at
corporate.ww.com.
For more information, contact:
Media:O'Licia
Parker-Smitholicia.parkersmith@ww.com
Investors:Corey Kingercorey.kinger@ww.com
-
https://www.healthsystemtracker.org/brief/how-much-and-why-2024-premiums-are-expected-to-grow-in-affordable-care-act-marketplaces/
- Derived from Sequence/WW virtual
clinic member data (n=1505) for which baseline and 12-month weights
were available
WW (NASDAQ:WW)
Gráfico Histórico do Ativo
De Abr 2024 até Mai 2024
WW (NASDAQ:WW)
Gráfico Histórico do Ativo
De Mai 2023 até Mai 2024